![Stevan F. Schweighardt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Stevan F. Schweighardt
Società | Posizione | Inizio | Fine |
---|---|---|---|
Bridge to Life Ltd.
![]() Bridge to Life Ltd. Medical SpecialtiesHealth Technology Bridge to Life Ltd. is a company that focuses on improving organ transplants by developing new preservation solutions and technologies. Bridge to Life is based in Northbrook, IL and has subsidiaries in Canada. The company is a leading supplier of preservation solutions worldwide and are currently enrolling patients in a study to evaluate the safety and effectiveness of the Vitasmart system. The company also has devices in development for lung and heart perfusion. The company was founded in 2005, and Donald J. Webber has been the CEO of the company since 2022. | Presidente | 01/01/2005 | - |
Amministratore Delegato | 01/01/2005 | 20/10/2022 |
Storia della carriera di Stevan F. Schweighardt
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Chief Executive Officer | 1 |
Chairman | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Bridge to Life Ltd.
![]() Bridge to Life Ltd. Medical SpecialtiesHealth Technology Bridge to Life Ltd. is a company that focuses on improving organ transplants by developing new preservation solutions and technologies. Bridge to Life is based in Northbrook, IL and has subsidiaries in Canada. The company is a leading supplier of preservation solutions worldwide and are currently enrolling patients in a study to evaluate the safety and effectiveness of the Vitasmart system. The company also has devices in development for lung and heart perfusion. The company was founded in 2005, and Donald J. Webber has been the CEO of the company since 2022. | Health Technology |